A randomised study of magnesium sulphate as an adjuvant to intrathecal bupivacaine in patients with mild preeclampsia undergoing caesarean section

International Journal of Obstetric Anesthesia

Volumn 19, Issue 2, 2010, Pages 161-166

  Malleeswaran, S ^a   Panda, N ^a   Mathew, P ^a   Bagga, R ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Caesarean delivery; Magnesium sulphate; NMDA antagonists; Postoperative analgesia; Spinal anaesthesia

Indexed keywords

BUPIVACAINE; DICLOFENAC; FENTANYL; MAGNESIUM SULFATE;

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HYPOTENSION; LETHARGY; NAUSEA; OUTCOME ASSESSMENT; PATIENT SATISFACTION; POSTOPERATIVE PAIN; PREECLAMPSIA; PROSPECTIVE STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; VOMITING;

ADULT; ANESTHETICS; BUPIVACAINE; CESAREAN SECTION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNESIUM SULFATE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77949571193     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijoa.2009.08.007     Document Type: Article

References (24)

1. Wallace D.H., Leveno K.J., Cunningham F.G., Giesecke A., Shearer V.E., and Sidawi J.E. Randomized comparison of general and regional anesthesia for cesarean delivery in pregnancies complicated by severe pre-eclampsia. Obstet Gynecol 86 (1995) 193-199
2. Karinen J., Rasanen S., Alahuhta S., Jouppila R., and Jouppila P. Maternal and uteroplacental haemodynamic state in pre-eclamptic patients during spinal anaesthesia for caesarean section. Br J Anaesth 76 (1996) 616-620
3. Hood D.D., and Curry R. Spinal versus epidural anesthesia for cesarean section in severely pre-eclamptic patients. Anesthesiology 90 (1999) 276-282
4. Roseag O.P., Lui C.P., Cicutti N.J., and Bragg P.R. Perioperative multimodal pain therapy for caesarean section: analgesia and fitness for discharge. Can J Anesth 44 (1997) 803-809
5. Schobel H.P., Fischer T., Heuszer K., Geiger H., and Schmieder R.E. Preeclampsia: a state of sympathetic overactivity. N Engl J Med 335 (1996) 1480-1485
6. Kroin J.S., McCarthy R.J., Von Roenn N., et al. Magnesium sulphate potentiates morphine antinociception at the spinal level. Anesth Analg 90 (2000) 913-917
7. Buvanendran A., McCarthy R.J., Kroin J.S., Leong W., Perry P., and Tuman K.J. Intrathecal magnesium prolongs fentanyl analgesia: a prospective, randomized, controlled trial. Anesth Analg 95 (2002) 661-666
8. Shoebi G., Sadegi M., Firazian A., and Tabassomi F. The additional effect of magnesium to lidocaine in spinal anaesthesia for caesarean section. Int J Pharmacol 3 (2007) 425-427
9. Ozalevli M., Cetin T.O., Unlugenc H., Guler T., and Isik G. The effect of adding intrathecal magnesium sulphate to bupivacaine fentanyl spinal anaesthesia. Acta Anaesthesiol Scand 49 (2005) 1514-1519
10. Mageed N.A., and El-Ghoniemy Y.F. Intrathecal fentanyl-magnesium for fast-track cardiac anaesthesia. Eg J Anaesth 21 (2005) 289-293
11. Arcioni R., Palmisoni S., Tigano S., et al. Combined intrathecal and epidural magnesium sulfate supplementation of spinal anesthesia to reduce post-operative analgesic requirements: a prospective, randomized, double-blind, controlled trial in patients undergoing major orthopedic surgery. Acta Anaesthesiol Scand 51 (2007) 482-489
12. Marzouk S., El-Hady N.A., Lotfy M., and Darwish H.M. The effect of three different doses of intrathecal magnesium sulphate on spinal opioid analgesia. Eg J Anaesth 19 (2003) 405-409
13. Chernik D.A., Gi1lings D., Laine H., Hendler J., Silver J., and Davidson A.B. Validity and reliability of the observer's assessment of alertness/sedation scale: Study with intravenous midazolam. J Clin Psychopharmacol 10 (1990) 244-251
14. Liu H.T., Hillman M.W., Liu W.H., et al. Modulation of NMDA receptor function by ketamine and magnesium. Part 2. Anesth Analg 92 (2001) 1173-1181
15. Woolf C.J., and Chong M.S. Preemptive analgesia-treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg 77 (1993) 362
16. Woolf C.J., and Thompson S.W. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 44 (1991) 293-299
17. Ascher P., and Nowak L. Electrophysiological studies of NMDA receptors. Trends Neurosci 10 (1987) 284-288
18. Ko S.H., Lim H.R., Kim D.C., Han Y.J., Choe H., and Song H.S. Magnesium sulfate does not reduce postoperative analgesic requirements. Anesthesiology 95 (2001) 640-646
19. Duley L., and Watkins K. Magnesium sulphate for treatment of preeclampsia: a trial to evaluate the effects on women and their babies. Contemp Rev Obstet Gynaecol 10 (1998) 267-274
20. Witlin A.G., and Sibai B.M. Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol 92 (1998) 883-889
21. Gurkan Y., and Toker K. Prophylactic ondansetron reduces the incidence of intrathecal fentanyl-induced pruritus. Anesth Analg 95 (2002) 1763-1766
22. Simpson J.I., Eide T.R., Schiff G.A., et al. Intrathecal magnesium sulphate protects the spinal cord from ischaemic injury during thoracic aorta cross clamping. Anesthesiology 81 (1994) 1493-1499
23. Takano Y., Sato E., Kaneko T., and Sato I. Antihyperalgesic effects of intrathecally administered magnesium sulphate in rats. Pain 84 (2000) 175-179
24. Chanimov M., Cohen M.L., Grinspun Y., et al. Neurotoxicity after spinal anaesthesia induced by serial injections of magnesium sulphate: an experimental study in a rat model. Anaesthesia 52 (1997) 223-228